138.
Casaburi R. A longterm evaluation of oneedaily inhaled tiotropium in
chronic obstructive pulmonary disease / R. Casaburi, D.A. Mahler, P.W. Jones
// Eur Respir
J
2002; - P. 19.
139
Chen W. The change of plasma level of endotlielin-1 in patients with
cor pulmonale and the effects of Captopril / W. Chen, D. Cheng // Hua Xi Yi
Ke Da Xue Xue Bao. 1999. - Vol. 30(2). - P. 179-181.
140.
Chiche J-D. Inhaled nitric oxide for right ventricular dysfunction in
chronic obstructive pulmonary disease patients: Fall or rise of an idea ’ J-D
Chiche, J. Dhainaut // Critical Care Medicine 1999. - V. 27. P. 2299- 2301.
141.
COMBI VENT Inhalation Aerosol Study Group. In chronic obstructive
pulmonary disease, a combination of ipratropium and albuterol is more effec
tive than either agent alone. An 85day multicenter trial. Chest.
1994 - - V
105. P. 1411-1419.
142.
Cuvelier A. Noninvasive ventilation and obstructive lung disease A.
Cuvelier, J.F. Mu i r / / Eur Respir J 2001; - V. 17 . - P . 1271-1281.
143.
Dahl R. Inhaled formoterol dry powder versus ipratropium bromide in
chronic obstructive pulmonary disease / R. Dahl // J Respir Crit Am Care
Med. - 2001. - V. 164. -P 778-784.
144.
Dart R. Treatment of systemic hypertension in patients with pulmonary
disease: COPD and asthma (special reports) / R. Dart, S. Gollub, J. Lazar /7
Chest. - 2003. - V. 123( I ). P. 22-43.
145
Disse B. DF 679 BR, a novel long acting anticholinergic bronchodila-
tor / B. Disse, R. Reichl, G. Speck // Life Sci. - 1993. - V. 52(56). P. 537-
544.
146.
Domicilary oxygen for COPD (Cochrane Review). In: The Cochrane
Library / Crockett AJ, Moss JR, Cranston JM, Alpers JM. - Issue 3. 2000 Ox
ford: Update Software.
147.
Dunnil M.S. A comparison of the quantitative anatomy of the bronchi
in normal subjects, in the status astlnnaticus in chronic bronchitis and in em-
